Baidu
map

中国台湾省新冠感染后轻症和无症状占99.8%,放宽解除隔离条件

2022-04-03 MedSci原创 MedSci原创

台湾地区流行疫情指挥中心4月3日公布,台湾新增280例新冠肺炎确诊病例,分别为183例本土确诊病例和97例输入病例,本土单日新增为今年新高。详细见:中国台湾省新增183例本土新冠病毒病的病例,连续多日

台湾地区流行疫情指挥中心4月3日公布,台湾新增280例新冠肺炎确诊病例,分别为183例本土确诊病例和97例输入病例,本土单日新增为今年新高。详细见:中国台湾省新增183例本土新冠病毒病的病例,连续多日创新高(2020.4.3)。事实上,台湾省一直是抗疫模范生,但是,在3月19日一场婚宴打破宁静,在3月21日梅斯首次进行了预警,见:中国台湾疫情会不会因为婚宴还始蔓延?到昨天,台湾省本土病例上升至183例。

台湾曾在2021年成功控制住新冠病毒的流行,当时台湾省一度濒临疫情崩溃状态,近2个月左右成功控制住疫情。因此,大家多戏称台湾抗疫为“模范生”。

预计此次疫情,台湾省疫情将以指数速度进行传播,防控的难度是极大的。

不过疫情指挥中心指挥官陈时中今(3日)表示,今年起至4月2日本土病例轻症者占99.8%,经专家会议后决定松绑确诊者的解除隔离条件。

陈时中表示,从1月1日至4月2日,本土病例共1530例,经分析其中轻症、无症状者有1527人、占99.80%,而中重症仅3人,占0.20%,因此经过医学专家会议讨论后,认为没有必要待在治疗场域的人可以及早离开,因此合理的放宽相关解除隔离条件。预计这一条件放宽,将有助于缓解医疗压力。

医疗应变组副组长罗一钧说明,因应境外移入以旧案居多,即日起修正无症状或轻症确诊个案解除隔离治疗条件。由于有些感染者Ct值一直无法两次达到30以上,因此针对新感染或初次PCR检测Ct值<30个案,移除“距发病日或探检日已达10天”条件。此外,初次PCR检测Ct值30的个案,移除“SARS-CoV-2anti-N抗体阳性”条件。

罗一钧说,入境确诊者如入境7天内解隔后仍需于防疫旅馆、检疫所或一人一户隔离至入境满10天,并于期满PCR采检,其他所有确诊者解隔后,需进行7天自主健康管理并进行2次快筛。

陈时中补充,随着时间过去,大家对病毒有更多的了解,尤其关于Ct值的检验,Ct值34以上基本上就没有传染力,都是病毒残留下的一些片段,现在也渐渐明白Ct值27-30间也几乎没有传播力,不过现在仍以Ct值大于等于30为标准。他强调,对于Ct值的了解、病毒的特性及兼顾病人权益及医疗量能,因此接受专家建议修订解隔条件,但后面的保险仍在,包括检疫仍要10天、检验PCR仍要阴性,自主健康管理维持7天,且有两次快筛。

梅斯医学预计,随着台湾省疫情的蔓延,接下来很可能会呈指数上升,至本月中旬可能会日增超过5万例,按照99.8%是轻症和无症状,意味着每日中重症人数控制在100例左右。同时,随着解除隔离条件的放宽,估计对医疗压力应该不大。通过有针对性治疗中重症,以及加宽隔离条件相结合,意味着台湾可能会不得不“躺平”。

内容综合自海峡导报等

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-07 weigq

    提供经验或教训。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-04 132e79b4m14暂无昵称

    疫情蔓延严重,疫情防控没小事

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-03 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2026247, encodeId=1f2b202624e56, content=<a href='/topic/show?id=5cf49105631' target=_blank style='color:#2F92EE;'>#解除隔离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91056, encryptionId=5cf49105631, topicName=解除隔离)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Tue Apr 12 05:02:48 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209127, encodeId=cce0120912ee1, content=提供经验或教训。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Apr 07 06:07:30 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485259, encodeId=0e5114852593b, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 05 12:02:48 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208475, encodeId=cbfc12084e5e0, content=疫情蔓延严重,疫情防控没小事, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4013587074, createdName=132e79b4m14暂无昵称, createdTime=Mon Apr 04 06:55:11 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208459, encodeId=04531208459b9, content=<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a><a href='/topic/show?id=1f773855eec' target=_blank style='color:#2F92EE;'>#台湾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情), TopicDto(id=38557, encryptionId=1f773855eec, topicName=台湾)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 23:05:21 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208452, encodeId=eba71208452a8, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Apr 03 22:36:47 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208429, encodeId=20e0120842974, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sun Apr 03 21:35:04 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-03 yangchou

    好文章,谢谢分享。

    0

相关资讯

国家卫健委:昨日新增1455+11691例,目前全国共有重症57例

4月2日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例1506例。其中境外输入病例51例(四川30例,广东10例,上海6例,福建3例,广西2例),含19例由无症状

2022年4月2日简报:上海昨日新增260+6051例;香港疫情连续7日下降,曾发现2例XE变种;陈尔真认为无症状感染者有条件的可以居家隔离

截至北京时间2022年4月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿8952万例,新增1,222,202例,达到489,520,

上海新增本土病例260+6051:上海疫情全新消息(2022.4.2)

其中2例确诊病例为此前无症状感染者转归,8例确诊病例和5402例无症状感染者在隔离管控中发现,其余在相关风险人群排查中发现。

香港新增4475例确诊,回落至5000例以内

自2月18日报告新增3269例确诊后,时隔一个半月,香港单日新增确诊回落至5000例以下。特区政府卫生署卫生防护中心传染病处主任张竹君4月2日下午通报,截至当日零时,香港新增2286例经核酸检测确诊的

吉林省新增本地感染者1730+1244:吉林疫情全新消息(2022.4.2)

4月1日0-24时,吉林省新增治愈出院确诊病例3914例,其中长春市2177例、吉林市1728例、延边州4例、四平市4例、松原市1例。

昨日新增本土2086+7789:4月2日新冠疫情情况通报

其中上海新增260+6051,全国现有确诊病例27128例(其中重症病例58例)。

Baidu
map
Baidu
map
Baidu
map